Healix Executive and Leadership Team

Brit Pim, the Chief Executive Officer at Healix, directs the overarching corporate strategy to maintain market leadership in physician office-based infusion services. Pim architects long-term growth initiatives that expand the reach of outpatient care solutions across North American markets. By aligning clinical excellence with business development, the Chief Executive Officer ensures that every infusion service meets rigorous safety and compliance standards. Pim fosters collaboration between internal departments to optimize patient outcomes and physician peace of mind. This leadership role involves constant evaluation of industry trends to refine service delivery models. Through the implementation of scalable operational frameworks, the Chief Executive Officer drives consistent performance across the entire organization. Ultimately, Pim secures the company's position as the premier provider of specialized infusion care by focusing on sustainable innovation and high-quality patient experiences.

Becky White-Steensma, the Chief Executive Officer & Founder at Healix, establishes the foundational vision for providing high-quality infusion services within physician offices. White-Steensma drives the strategic mission to enhance patient care and clinical outcomes through specialized outpatient settings. Overseeing the long-term trajectory of the organization, the Chief Executive Officer & Founder ensures that the core values of compliance and comfort remain central to every service offering. White-Steensma manages high-level relationships with healthcare partners to expand the national footprint of the company. By championing a culture of excellence, the Chief Executive Officer & Founder guides the executive team toward achieving ambitious growth targets. This leadership role requires deep industry expertise to navigate the complexities of the infusion market. Through persistent dedication to the original mission, White-Steensma maintains the company's reputation as a trusted leader in the healthcare sector.

Melisa Norton, the Chief Financial Officer at Healix, manages the fiscal health and capital allocation strategies necessary to support nationwide infusion service operations. Norton oversees financial planning, budgeting, and revenue cycle management to ensure the company maintains robust economic stability. By analyzing market data, the Chief Financial Officer identifies opportunities for investment in new clinical technologies and infrastructure. Norton collaborates with the executive team to align financial goals with the broader mission of providing optimal patient care. This leadership role involves rigorous oversight of accounting practices and regulatory reporting to guarantee transparency. Through the implementation of efficient financial controls, Norton supports the expansion of office-based infusion programs across diverse regional markets. Ultimately, the Chief Financial Officer drives the fiscal discipline required to sustain long-term growth and operational excellence within the competitive healthcare landscape.

Casey Lucas, the Chief Operating Officer & Executive VP, Sales at Healix, directs the daily operational workflows and sales strategies that facilitate the delivery of infusion services. Lucas oversees the expansion of sales territories to increase the adoption of office-based infusion models among healthcare providers. By streamlining internal processes, the Chief Operating Officer & Executive VP, Sales ensures that clinical teams operate with maximum efficiency and compliance. Lucas manages the integration of new service sites to maintain consistent quality standards across the national network. This leadership role involves coordinating with clinical staff to refine patient care protocols and service delivery. Through the execution of targeted sales initiatives, Lucas drives revenue growth and strengthens market presence. Ultimately, the Chief Operating Officer & Executive VP, Sales optimizes the intersection of operational performance and commercial success to benefit both physicians and patients.

Mark Winters, the Partner, Executive Board Member, President at Healix, provides high-level strategic direction and governance to ensure the company achieves its long-term objectives. Winters oversees the alignment of board-level initiatives with the operational goals of the infusion service business. By participating in key decision-making processes, the Partner, Executive Board Member, President shapes the corporate culture and commitment to clinical excellence. Winters collaborates with other executives to evaluate market opportunities and drive organizational growth. This leadership role involves representing the company's interests to stakeholders and ensuring the sustainability of the business model. Through the application of deep industry knowledge, Winters guides the executive team in navigating the evolving healthcare landscape. Ultimately, the Partner, Executive Board Member, President drives the strategic vision that sustains the company's reputation as a leader in physician office-based infusion services.

Tom Reinckens, the Chief Information & Procurement Officer at Healix, manages the technological infrastructure and supply chain logistics essential for infusion service delivery. Reinckens architects secure data systems that support clinical compliance and patient information management. By overseeing the procurement of medical supplies, the Chief Information & Procurement Officer ensures that all infusion sites maintain access to high-quality medications and equipment. Reinckens coordinates with vendors to negotiate favorable terms that support the company's cost-efficiency goals. This leadership role involves implementing digital solutions that enhance the accuracy of clinical documentation and reporting. Through the optimization of supply chain networks, Reinckens minimizes disruptions and supports the seamless operation of outpatient infusion services. Ultimately, the Chief Information & Procurement Officer drives the technological and logistical advancements required to maintain the company's competitive edge in the healthcare industry.

Blake Griese, the General Counsel & Head of Pharmacy at Healix, directs the legal framework and pharmaceutical operations that govern infusion service delivery. Griese oversees regulatory compliance to ensure that all clinical practices adhere to national healthcare standards. By managing the pharmacy division, the General Counsel & Head of Pharmacy ensures the safe and accurate preparation of infusion medications. Griese provides legal guidance on corporate governance and risk management to protect the organization's interests. This leadership role involves navigating complex healthcare regulations to support the expansion of office-based infusion programs. Through the integration of legal oversight and pharmaceutical expertise, Griese maintains the integrity of the company's clinical outcomes. Ultimately, the General Counsel & Head of Pharmacy drives the development of policies that prioritize patient safety and regulatory adherence across all operational regions.